Share
688 Posts.
lightbulb Created with Sketch. 107
clock Created with Sketch. 26/06/23
11:23
Share
Originally posted by TheAnalyst007:
↑
At the moment it's about US$50,000 per doctor per year. I suspect this should increase significantly as most doctors will likely increase their usage of the procedure now that it is much easier and efficient to use. It's recurring revenue (due to single use nature of the device) which will necessarily mean it will command a higher valuation multiple. Even more, the legacy device has proved that customer retention is very high so once the company has penetrated the market they should be able to significantly ease up on the marketing spend (boosting bottom line performance).
Expand
I am amazed that there is no imbursement for canaloplasty in Australia. I have seen a lot of i stents inserted for glaucoma here. Has the company ever approached the TGA or are things in the pipeline?
(20min delay)